MicroRNAs in Hearing Disorders: Their Regulation by Oxidative Stress, Inflammation and Antioxidants

Kedar N Prasad1, Stephen C Bondy2

  • 1Engage GlobalSan Rafael, CA, United States.

Insights

MicroRNAs (miRs) are implicated in hearing disorders. Oxidative stress and inflammation may damage inner ear cells by altering miR expression, while antioxidants might protect by modulating miRs.

Area of Science:

  • Oto-neurology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRs) regulate gene expression and are vital for inner ear cell function.
  • Dysregulation of miRs is increasingly linked to the pathogenesis of hearing disorders.
  • Oxidative stress and inflammation are known contributors to hearing loss, but their precise molecular mechanisms involving miRs remain unclear.

Purpose of the Study:

  • To explore the role of microRNA alterations in the pathogenesis of hearing disorders.
  • To investigate whether oxidative stress and inflammation damage inner ear cells by modulating microRNA expression.
  • To examine the potential protective mechanisms of antioxidants against hearing disorders via microRNA regulation.

Main Methods:

  • Review of existing literature on microRNAs, oxidative stress, inflammation, and hearing disorders.
  • Analysis of evidence from neuronal and non-neuronal cells regarding the effects of reactive oxygen species (ROS) and pro-inflammatory cytokines on microRNA expression.
  • Examination of data on antioxidant effects on microRNA expression in mammalian cells.

Main Results:

  • Alterations in microRNA expression are proposed as a factor in hearing disorder development.
  • Evidence suggests that oxidative stress and inflammation may damage inner ear cells through microRNA dysregulation, similar to mechanisms observed in neuronal cells.
  • Antioxidants demonstrate a capacity to protect mammalian cells from oxidative damage by altering microRNA expression.

Conclusions:

  • MicroRNA dysregulation is a potential contributor to the pathogenesis of hearing disorders.
  • Oxidative stress and inflammation may induce hearing loss by altering microRNA expression in inner ear cells.
  • Antioxidants may offer protection against hearing disorders by modulating microRNA expression, warranting further investigation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K